End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.75 CNY | +0.09% | +8.00% | +20.02% |
04-29 | Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.02% | 2.18B | |
+8.05% | 72.03B | |
-11.95% | 5.14B | |
+51.87% | 4.6B | |
+3.92% | 3.96B | |
-14.26% | 2.5B | |
+20.42% | 2.43B | |
-23.94% | 2.32B | |
+3.66% | 1.72B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 600420 Stock
- News Shanghai Shyndec Pharmaceutical Co., Ltd.
- Shyndec Pharma Unit's Cefotaxime Sodium for Injection Passes Drug Regulator's Consistency Evaluation